Xofigo Radiopharm
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 24AP1993JA
- Agency
- Veterans Integrated Service Network 4 Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36C24424P0494 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Philadelphia, Pennsylvania 19104, United States
- Points of contact
-
- Roger Tang roger.tang@va.gov (215) 823-5800
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 4 issued a Justification and Approval (J&A) for Other Than Full and Open Competition to acquire radiopharmaceuticals, including Xofigo Injection, Fluedoxyglucose (FDG), and Sodium Fluoride (NaF). Bayer HealthCare Pharmaceuticals, Inc. is the sole manufacturer of Xofigo, and Cardinal Health 414 is the only authorized distributor. The total estimated quantities are 2,820 units of Xofigo, 1,000 units of FDG, and 10 units of NaF, with a total estimated value of the proposed action. The contract will be awarded directly to Cardinal Health 414 for a period of performance from 04-12-2024 through 4-11-2025, citing the statutory authority of 41 USC 3304(a)(1) as only Bayer and Cardinal can meet the agency's requirements for these specialized radiopharmaceuticals.
Notice text
Xofigo Injection
Awarded contract 36C24424P0494 to unknown vendor for unknown amount on 2024-04-11.
Attachments
| File | Type | Posted |
|---|---|---|
| P03 Radiopharm J A FY24 April Cardinal Xofigo March 7 fully signed print_Redacted.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity